Refine by
Vascular Surgery Articles & Analysis
62 news found
Hemostemix Inc. (TSX-V: HEM; OTCQB: HMTXF; FSE: 2VF0), an autologous stem cell company developing and commercializing VesCell™ (ACP-01), announces the appointment of a seasoned commercial team encompassing marketing, sales, e-commerce and patient care communications, in compliance with federal and state regulations. The appointments enable Hemostemix to sell VesCell™ in Florida to ...
Hemostemix (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company“) is excited to highlight a groundbreaking research article published in Cells on June?29,?2025, by Dr. Fraser C. Henderson Sr. and Ms. Kelly?Tuchman, exploring how a combination of the patient’s own ACP-01 and NCP-01 (autologous blood-derived cell precursors) may support the long-term ...
Hemostemix (TSXV: HEM) (OTCQB: HMTXF) (FSE: 2VF0) (“Hemostemix” or the “Company“) is excited to highlight a groundbreaking research article published in Cells on June?29,?2025, by Dr. Fraser C. Henderson Sr. and Ms. Kelly?Tuchman, exploring how a combination of the patient’s own ACP-01 and NCP-01 (autologous blood-derived cell precursors) may support the long-term ...
At present, many surgeries have entered the robot era, and traditional surgery is being changed because of the addition of robots.Surgical robots can help doctors to develop surgical plans, improve the accuracy of surgical procedures, and transform traditional techniques into digital procedures. Thanks to the development of mechanical control, visual imaging, ...
Inari Medical, Inc. (NASDAQ: NARI) (“Inari”) a medical device company focused on developing products to treat and transform the lives of patients suffering from venous and other diseases, announced positive in-hospital and 30-day outcomes from the fully-enrolled 500-patient CLOUT registry. The company also reported positive results from a propensity-matched comparison of patients ...
Alucent Biomedical, a privately held medical technology company founded to transform the way vascular disease is treated, today announced Venita Chandra, M.D., will join the company’s scientific advisory board. ...
Steven Abramowitz, Co-Principal Investigator and Chair of Vascular Surgery at MedStar Heath. “PTS is a debilitating condition with symptoms including swelling, difficulty walking, skin changes and poorly healing open wounds. ...
A lower extremity bypass procedure - like any surgery - can be more difficult as we age. The bad news was that the best veins for the procedure - which involves grafting a vein from another part of the body to bypass her blocked arteries in the leg - were unusable. ...
About TeraRecon: Serving 1,300 clinical sites globally, TeraRecon, a ConcertAI company, is a Best in KLAS solution provider for AI-empowered radiology, oncology, cardiology, neurology, and vascular surgery. Awarded the 2020, 2021, and 2022 KLAS Category Leader for Advanced Visualization, TeraRecon solutions are independent of any one manufacturer’s imaging ...
The Intuition Titanium Suite, recently contracted by DocPanel, includes all the KLAS-leading clinical features to serve the needs of image-driven physicians across multiple service lines, including radiology, cardiology, and vascular surgery, neurology, and pulmonology. About DocPanel: DocPanel is the world’s first radiology marketplace, offering the ...
Amsel Medical Corp. today announced the appointment of Lowell S. Kabnick as a consultant acting as Director of Clinical and Medical Affairs, as the company advances the current product commercialization phase to address the demand for minimally invasive, simple and secure occlusion. In addition to serving as the Chancellor of the Vein & Lymphatic University, Dr. Kabnick is the previous ...
This technique has been endorsed by various medical and surgical societies like the European society of vascular surgery which promotes it in appropriate groups of patients. Carbon dioxide has the unique properties of lack of renal and liver toxicity, good solubility (leading to quick dissolution in blood stream), good patient tolerance limits and safe lung ...
MINNEAPOLIS, June 10, 2021 - CVRx©. developer of the world's first FDA-approved neuromodulation device to treat the symptoms of heart failure (HF). announced the completion of the first clinical procedure with the company's new lead implantation approach. The novel ultrasound-guided technique is the latest advancement of CVRx's Barostim™ Baroreflex Activation Therapy (BAT™) to ...
ByCVRx
Bluegrass Vascular Technologies, a private medical technology company focused on innovating lifesaving devices and methods for vascular access procedures, announced today the publication of a paper featured on the cover of the June 2022 issue of the Journal of Vascular Surgery (JVS) which reports on the use the Surfacer System to ...
Kasuo Miyake, MD-PhD, is one of the world’s leading vascular surgeons, respected for his contribution to the development of new techniques for different types of varicose vein treatment. ...
” Silk Road Medical had previously submitted a PMA supplement, which included data extracted from the Vascular Quality Initiative. The surveillance data included in the submission represented real-world outcomes in 20,264 patients considered at standard surgical risk. ...
Ended the Year With $55 Million in Cash Expected To Fund Operations Through the End of 2024 Including Release of Topline Pivotal Trial Data Nine (9) VenoValve Surgeries Successfully Completed and 16 Clinical Sites Currently Active in Ongoing SAVVE U.S Pivotal Trial Continued Advancement in Development of Second Device for the Treatment of Venous Disease Expected To Be ...
“The key goal is to be able to detect the problems associated with microvascular and vascular surgeries with high risk of post-op complications,” said Sonavex CEO David Narrow. A complication of microvascular surgery—used to reattach severed body parts such as fingers and hands by reconnecting tiny blood vessels and restoring ...
Godshall held various executive and leadership positions at Boston Scientific, where he served as President of the Vascular Surgery Division, as a member of Boston Scientific’s Operating Committee and as Vice President of Business ...
He is recognized as a Key Opinion Leader on the diabetic foot, lower extremity wound care, limb salvage, podiatric medicine, and surgery. Chief Strategy Officer – Douglas W.F. LeFort provides extensive experience in senior executive leadership across SME, FTSE 250, and Fortune 500 companies. ...